| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 13.82M | — |
| Operating expense | — | — |
| Net income | -22.86M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AQST returned +17.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.9% |
| 1 year | +17.1% |
| 5 years | +1.7% |
| All-time high | $18.01 (Aug 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AQST would be worth today ›No. Aquestive Therapeutics, Inc. has not paid a dividend in the past 12 months.
Aquestive Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol AQST.
Aquestive Therapeutics, Inc. is part of the Healthcare sector.
Aquestive Therapeutics, Inc. has a market cap of 584.88M USD, based on the latest quote.
Aquestive Therapeutics, Inc. is scheduled to report earnings on Nov 4, 2026.
